Showing results (451-460 of 638) with videos related to

Sort By:
Pageof 64
Cancer|December 31, 2013
Patient-reported outcomes in women with breast cancer enrolled in a dual-center, double-blind, randomized controlled trial assessing the effect of acupuncture in reducing aromatase inhibitor-induced musculoskeletal symptomsTing Bao, Ling Cai, Claire Snyder, et al.
Endocrine-Related Cancer|September 24, 2010
Suppression of relaxin receptor RXFP1 decreases prostate cancer growth and metastasisShu Feng, Irina U Agoulnik, Anne Truong, et al.
Oncotarget|February 27, 2016
Therapeutic evaluation of microRNA-15a and microRNA-16 in ovarian cancerShailendra Kumar Dhar Dwivedi, Soumyajit Banerjee Mustafi, Lingegowda S Mangala, et al.
Cellular Signalling|January 15, 2020
GATA3 as a master regulator for interactions of tumor-associated macrophages with high-grade serous ovarian carcinomaAmr Ahmed El-Arabey, Merve Denizli, Pinar Kanlikilicer, et al.
Hepatology (Baltimore, Md.)|February 8, 2013
Tat-activating regulatory DNA-binding protein regulates glycolysis in hepatocellular carcinoma by regulating the platelet isoform of phosphofructokinase through microRNA 520Yun-Yong Park, Sang-Bae Kim, Hee Dong Han, et al.
Carcinogenesis|January 1, 2014
EDD enhances cell survival and cisplatin resistance and is a therapeutic target for epithelial ovarian cancerAmber Bradley, Hui Zheng, Angela Ziebarth, et al.
Oncotarget|August 6, 2020
Therapeutic efficacy of liposomal Grb2 antisense oligodeoxynucleotide (L-Grb2) in preclinical models of ovarian and uterine cancerOlivia D Lara, Emine Bayraktar, Paola Amero, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 6, 2005
Antitumor activity in melanoma and anti-self responses in a phase I trial with the anti-cytotoxic T lymphocyte-associated antigen 4 monoclonal antibody CP-675,206Antoni Ribas, Luis H Camacho, Gabriel Lopez-Berestein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2012
Endoglin (CD105) contributes to platinum resistance and is a target for tumor-specific therapy in epithelial ovarian cancerAngela J Ziebarth, Somaira Nowsheen, Adam D Steg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 12, 2018
Dual Suppressive Effect of miR-34a on the FOXM1/eEF2-Kinase Axis Regulates Triple-Negative Breast Cancer Growth and InvasionRecep Bayraktar, Cristina Ivan, Emine Bayraktar, et al.
Pageof 64